Roadmap for Development of Competition in Healthcare
Print
30 January 2018
GMP News
In December 2017 the Russian President approved the National Plan for the Development of Competition. This is a cross-industrial document which requires elaboration of sector-specific roadmaps.
In January 2018 the Russian Government signed the Decree No. 9-r, which approves the Roadmap for Development of Competition in Healthcare (Roadmap).
This video provides a brief overview of the most essential Roadmap provisions related to medicines.
All Portfolio
MEDIA CENTER
-
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.